Competitive Technologies launches noninvasive pain therapy in US
This article was originally published in Clinica
Executive Summary
Competitive Technologies (CTT) has launched its Calmare pain management device in the US. The system, which uses electrodes that are applied to the surface of the skin, is now available at Calmar Pain Relief's Pain Therapy Center in North Providence, Rhode Island for treating high-intensity oncologic and neuropathic pain. It transmits "non-pain" information rather than blocking pain transmission, and avoids the side-effects associated with narcotic painkillers, including addiction. Calmar plans to open similar clinics in 10 more US cities in the next 24 months. The device has received 510(k) clearance from the US FDA and is CE marked for sale in Europe. CTT estimates that the global pain market will reach $40bn this year.